Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson's disease.

Signal Transduct Target Ther · 2025 · PMC11718261 · PMID 39788941

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

1c ) and a marginal significance for increased phase-amplitude coupling.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.